ADRIAMYCIN CARDIAC TOXICITY. A DIFFERENT HYPOTHESIS.BYFIELD JE.1977; CANCER TREATM. REP.; U.S.A.; DA. 1977; VOL. 61; NO 3; PP. 497-498; BIBL. 15 REF.Article

INDUCTION OF DNA DEGRADATION IN VIVO BY ADRIAMYCIN.LEE YC; BYFIELD JE.1976; J. NATION. CANCER INST.; U.S.A.; DA. 1976; VOL. 57; NO 1; PP. 221-224; BIBL. 26 REF.Article

IRREPARABLE DNA CROSS-LINKS AND MAMMALIAN CELL LETHALITY WITH BIFUNCTIONAL ALKYLATING AGENTSMURNANE JP; BYFIELD JE.1981; CHEM.-BIOL. INTERACT.; ISSN 0009-2797; NLD; DA. 1981; VOL. 38; NO 1; PP. 75-86; BIBL. 42 REF.Article

CARRIER-DEPENDENT AND CARRIER-INDEPENDENT TRANSPORT OF ANTI-CANCER ALKYLATING AGENTSBYFIELD JE; CALABRO JONES PM.1981; NATURE (LOND.); ISSN 0028-0836; GBR; DA. 1981; VOL. 294; NO 5838; PP. 281-283; BIBL. 52 REF.Article

EFFECT OF 5-FLUOROURACIL AND ACTINOMYCIN D ON REPAIR OF DNA SINGLE-STRAND BREAKS IN CERVIX CANCER CELLSBYFIELD JE; YOUNG CHANG LEE.1973; J. NATION. CANCER INST.; U.S.A.; DA. 1973; VOL. 50; NO 2; PP. 573-575; BIBL. 5REF.Article

X-RAY EXCISION REPAIR REPLICATION AND RADIATION SURVIVAL IN PLACENTAL MAMMAL CELLS.BYFIELD JE; LEE YC; KULHANIAN F et al.1976; INTERNATION. J. RAD. ONCOL. BIOL. PHYS.; U.S.A.; DA. 1976; VOL. 1; NO 9-10; PP. 937-943; BIBL. 31 REF.Article

MOLECULAR INTERACTIONS BETWEEN ADRIAMYCIN AND X-RAY DAMAGE IN MAMMALIAN TUMOR CELLS.BYFIELD JE; LEE YC; TU L et al.1977; INTERNATION. J. CANCER; SWITZ.; DA. 1977; VOL. 19; NO 12; PP. 186-193; ABS. FR.; BIBL. 1 P. 1/2Article

COMBINATION INFUSIONAL 5-FLUOROURACIL AND RADIATION THERAPY FOR THE TREATMENT OF METASTATIC CARCINOMA OF THE COLON TO THE LIVER. DISCUSSIONBARONE RM; BYFIELD JE; FRANKEL S et al.1979; DIS. COLON RECTUM; USA; DA. 1979; VOL. 22; NO 6; PP. 376-386; BIBL. 8 REF.Article

MURINE NEUROBLASTOMA CURED IN VIVO BY AND ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY REACTION.BYFIELD JE; ZERUBAVEL R; FONKALSRUD EW et al.1976; NATURE; G.B.; DA. 1976; VOL. 264; NO 5588; PP. 783-785; BIBL. 28 REF.Article

ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY-MEDIATED SEROTHERAPY AGAINST MURINE NEUROBLASTOMA. I: IN VITRO AND IN VIVO TREATMENT USING NORMAL, GAMMA -IRRADIATED AND IMMUNE-STIMULATED RAT EFFECTOR CELLSBYFIELD JE; ZERUBAVEL R; FONKALSRUD EW et al.1982; CANCER IMMUNOL. IMMUNOTHER.; ISSN 0340-7004; DNK; DA. 1982; VOL. 14; NO 2; PP. 117-123; BIBL. 20 REF.Article

EFFECTS OF METHYLATED XANTHINES ON MAMMALIAN CELLS TREATED WITH BIFUNCTIONNAL ALKYLATING AGENTSMURNANE JP; BYFIELD JE; WARD JF et al.1980; NATURE; GBR; DA. 1980; VOL. 285; NO 5673; PP. 326-329; BIBL. 42 REF.Article

BLEOMYCIN: ITS UTILIZATION IN THE TREATMENT OF HEAD AND NECK CANCERBONE RC; BYFIELD JE; FEREN AP et al.1979; LARYNGOSCOPE; USA; DA. 1979; VOL. 89; NO 2; PP. 224-233; BIBL. 21 REF.Article

UNRESECTABLE SQUAMOUS CELL CARCINOMA OF THE LUNG AND ITS MANAGEMENT BY COMBINED BLEOMYCIN AND RADIOTHERAPY. A CLINICAL STUDY OF THE ENHANCED RESULTS.CHAN PYM; BYFIELD JE; KAGAN AR et al.1976; CANCER; U.S.A.; DA. 1976; VOL. 37; NO 6; PP. 2671-2676; BIBL. 15 REF.Article

IMPROVED LIQUID CHROMATOGRAPHIC ASSAY FOR SERUM FLUOROURACIL CONCENTRATIONS IN THE PRESENCE OF FTORAFURHORNBECK CL; FLOYD RA; GRIFFITHS JC et al.1981; J. PHARM. SCI.; ISSN 0022-3549; USA; DA. 1981; VOL. 70; NO 10; PP. 1163-1166; BIBL. 10 REF.Article

MOLECULAR INTERACTIONS OF THE COMBINED EFFECTS OF BLEOMYCIN AND X-RAYS ON MAMMALIAN CELL SURVIVALBYFIELD JE; LEE YC; TU L et al.1976; CANCER RES.; U.S.A.; DA. 1976; VOL. 36; NO 3; PP. 1138-1143; BIBL. 39 REF.Article

PHARMACOLOGIC REQUIREMENTS FOR OBTAINING SENSITIZATION OF HUMAN TUMOR CELLS IN VITRO TO COMBINED 5-FLUOROURACIL OR FTORAFUR AND X RAYSBYFIELD JE; CALABRO JONES P; KLISAK I et al.1982; INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY, BIOLOGY, PHYSICS; ISSN 0360-3016; USA; DA. 1982; VOL. 8; NO 11; PP. 1923-1933; BIBL. 48 REF.Article

EFFECT OF DIFFERENTIATION ON THE REPAIR OF DNA SINGLE STRAND BREAKS IN NEUROBLASTOMA CELLSBYFIELD JE; LEEN YC; KLISAK I et al.1975; BIOCHEM. BIOPHYS. RES. COMMUNIC.; U.S.A.; DA. 1975; VOL. 63; NO 3; PP. 730-735; BIBL. 22REFArticle

X-RAY REPAIR REPLICATION IN L1210 LEUKEMIA CELLS = LA REPLICATION DE REPARATION DES RAYONS X DANS LES CELLULES DE LA LEUCEMIE L1210LEE YC; BYFIELD JE; BENNETT LR et al.1974; CANCER RES.; U.S.A.; DA. 1974; VOL. 34; NO 10; PP. 2624-2633; BIBL. 31REF.Article

INTRA-ARTERIAL CHEMOTHERAPY USING AN IMPLANTABLE INFUSION PUMP AND LIVER IRRADIATION FOR THE TREATMENT OF HEPATIC METASTASESBARONE RM; BYFIELD JE; GOLDFARB PB et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 50; NO 5; PP. 850-862; BIBL. 17 REF.Article

MICE, MEN, MUSTARDS AND METHYLATED XANTHINES: THE POTENTIAL ROLE OF CAFFEINE AND RELATED DRUGS IN THE SENSITIZATION OF HUMAN TUMOURS TO ALKYLATING AGENTSBYFIELD JE; MURNANE J; WARD JF et al.1981; BR. J. CANCER; ISSN 0007-0920; GBR; DA. 1981; VOL. 43; NO 5; PP. 669-683; BIBL. 2 P.Article

INFUSIONAL 5-FLUOROURACIL AND X-RAY THERAPY FOR NON-RESECTABLE ESOPHAGEAL CANCERBYFIELD JE; BARONE R; MENDELSOHN J et al.1980; CANCER; USA; DA. 1980; VOL. 45; NO 4; PP. 703-708; BIBL. 14 REF.Article

SURGICAL ADJUVANT THERAPY IN COLON CARCINOMA: A HUMAN TUMOR SPHEROID MODEL FOR EVALUATING RADIATION SENSITIZING AGENTSBARONE RM; CALABRO JONES P; THOMAS TN et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 47; NO 10; PP. 2349-2357; BIBL. 23 REF.Article

COMBINATION ADRIAMYCIN AND RADIATION THERAPY IN GYNECOLOGIC CANCERS = L'ASSOCIATION DE L'ADRIAMYCINE ET DE LA RADIOTHERAPIE DANS LES CANCERS GYNECOLOGIQUESWATRING WG; BYFIELD JE; LAGASSE LD et al.1974; GYNECOL. ONCOL.; U.S.A.; DA. 1974; VOL. 2; NO 4; PP. 518-526; BIBL. 1P.Article